STAT Plus: The Alzheimer’s Drug Discovery Foundation still expects new treatment options approved by 2025
COURTESY MILKEN INSTITUTE
The group’s executive director, Dr. Howard Fillit, insisted in an interview that the industry is on the cusp of some breakthroughs.
No hay comentarios:
Publicar un comentario